EU approves Sanofi’s Dupixent for the treatment of “light smokers”
Sanofi and partner Regeneron on Wednesday won European Union approval for wider use of the injectable drug Dupixent in patients with chronic lung disease, a rare case of the EU approving a drug faster than the US.
POPULAR POSTS
Bluetongue outbreak in a Portuguese sheep farm has broken out
September 19, 2024
Austria says disaster fund to rise to 1 billion euros
September 19, 2024
Portugal gets help from Spain and Morocco in response to fires
September 19, 2024
Drought reduces Amazon rivers to historic lows
September 19, 2024
LIVE STREAM